Topics
View Supplement
Supanji Supanji, MD, MSc, PhD; Dinda Ajeng Anindita, MD; Izzati Amayazifun Khalifa Farzana, MD; Anindita Dianratri, MD; Widya Ardhana Reswari, MD; Nurul Imawati, MD; Imam Tiharyo, MD, MSc; and Muhammad Bayu Sasongko, MD, MEPID, PhD
Peter K. Kaiser, MD, and Charles C. Wykoff, MD, PhD
Matthew A. Cunningham, MD, and Jaya B. Kumar, MD
January/February 2022 Insert
Supported by Allergan, an AbbVie company
January/February 2022 Supplement
This activity is supported by an unrestricted educational grant from Bausch + Lomb.
Recent Supplements
Understanding Fast Progression in Geographic Atrophy
View Insert
Gaining Patients’ Buy-in With Geographic Atrophy Treatment: The Journey From Diagnosis to Long-term Adherence
Editorially Independent Content, Supported With Advertising From Astellas
Business Matters: When and How To Hire
Editorially independent content supported with advertising by EyePoint
One to Watch: Samir N. Patel, MD
Editorially independent supported by Abbvie and Regenxbio
Rising Stars in Retina: Prashant D. Tailor, MD
Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease
This activity is supported by an independent educational grant from EyePoint Pharmaceuticals.
View More
Eyetube Retina Series
EYETUBE RETINA MEETING COVERAGE